Andrea I. Havasi, MD

Assistant Professor of Medicine
Department of Medicine / Renal Section / Amyloidosis Center
Co-Director, Mitochondria Affinity Research Collaborative
Director, Nephrology Fellowship Program's Onco-nephrology / Amyloidosis Pathway
Boston University Medical Center
Boston, Massachusetts, United States
Andrea Havasi, MD is an Assistant Professor of Medicine at Boston University. She is board certified in Internal Medicine and Nephrology. As a recipient of the National Kidney Foundation Research Fellow Award, she undertook research training at Boston Medical Center investigating the cytoprotective mechanisms of heat shock proteins in ischemic renal cell injury and apoptosis.
 
She joined the Renal Section Faculty in 2008, and continues translational research in the area of renal cell injury and proteinuric kidney diseases using cell culture and animal models. She was the recipient of the American Heart Association Scientist Development Grant and the NIH K08 award investigating the mechanisms of proteinuria induced tubular damage, interstitial fibrosis and inflammation in progressive kidney diseases with the goal of developing of new therapeutic tools to prevent or slow the progression of proteinuric chronic kidney disease. She is also involved in clinical research focusing specifically on amyloidosis.
 

She has a special clinical and research interest in onco-nephrology and amyloidosis, and is a faculty in BU’s Amyloidosis Center and member of the Evans Center for Interdisciplinary Biomedical Research. Dr. Havasi is the Director of Nephrology Fellowship Program’s Onco-nephrology / Amyloidosis Pathway. Her clinical roles include attending time on the consult and dialysis/transplant services and weekly outpatient clinics (amyloidosis, chronic kidney disease, hemodialysis and peritoneal dialysis clinics).

Her current research interests include amyloid renal disease focusing on mechanisms of amyloid fibril formation and deposition in the kidney. Her weekly amyloidosis clinic has exposed her to the many problems facing amyloidosis patients and created a keen passion to identify and develop new treatment options for amyloidosis patients. She established a productive collaboration with the Amyloid Research Laboratory at Boston University. The main aim of their program is to determine the mechanisms involved in direct kidney cell toxicity. By understanding the mechanism causing kidney cell toxicity they hope to get closer to finding a therapy which can potentially prevent or cure kidney damage in patients with plasma cell dyscrasia. 

Dr. Havasi has been working to raise awareness of amyloidosis among clinicians and patients to facilitate early diagnosis and treatment that will translate into better patient outcomes and quality of life.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close